Automated description from the Alliance of Genome Resources (Release 6.0.0)
Predicted to enable beta-catenin binding activity and cadherin binding activity. Predicted to be a structural constituent of postsynaptic density. Acts upstream of or within learning; morphogenesis of a branching structure; and regulation of synaptic plasticity. Located in postsynaptic density. Is expressed in several structures, including central nervous system; future brain; lung; sensory organ; and spinal ganglion. Human ortholog(s) of this gene implicated in anxiety disorder; major depressive disorder; and schizophrenia. Orthologous to human CTNND2 (catenin delta 2).